Article
Rare damaging <i>CCR2</i> variants are associated with lower lifetime cardiovascular risk
2023-08-16
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> Previous work has shown a role of CCL2, a key chemokine governing monocyte trafficking, in atherosclerosis. However, it remains unknown whether targeting CCR2, the cognate receptor of CCL2, provides protection against human atherosclerotic cardiovascular disease. <h4>Methods</h4> Computationally predicted damaging or loss-of-function (REVEL>0.5) variants within CCR2 were d...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6628cb7c-9544-575d-a1f3-607e6106d3e9
- DOI
- 10.1101/2023.08.14.23294063
